ES2091818T3 - Preparado farmaceutico util en el tratamiento de la amigdalitis. - Google Patents

Preparado farmaceutico util en el tratamiento de la amigdalitis.

Info

Publication number
ES2091818T3
ES2091818T3 ES90903444T ES90903444T ES2091818T3 ES 2091818 T3 ES2091818 T3 ES 2091818T3 ES 90903444 T ES90903444 T ES 90903444T ES 90903444 T ES90903444 T ES 90903444T ES 2091818 T3 ES2091818 T3 ES 2091818T3
Authority
ES
Spain
Prior art keywords
treatment
ncib
beta
pharmaceutical preparation
tonsillitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90903444T
Other languages
English (en)
Inventor
Eva Elisabeth Grahn
Stig Edvin Folke Holm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2091818T3 publication Critical patent/ES2091818T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UN PREPARADO FARMACEUTICO PARA LA PROFILAXIS Y/O EL TRATAMIENTO DE LA TONSILITIS (BETA)-ESTREPTOCOCICA. EL PREPARADO INCLUYE AL MENOS UNA CAPA DE MICRO-ORGANISMO VIABLE SELECCIONADO DEL GRUPO COMPUESTO DE CAPAS DE ESTREPTOCOCOS SANGUIS II CON NUMEROS DE DEPOSITO NCIB 40104, NCIB 40105 Y NCIB 40106, LA CEPA DE ESTREPTOCOCOS MITIS CON EL NUMERO DE DEPOSITO NCIB 40107 Y CEPAS DE ESTREPTOCOCO CON LA MISMA CAPACIDAD ESENCIAL INHIBIDORA DEL (BETA)-ESTREPTOCOCO QUE LAS CEPAS PRECIPITADAS EN UN MEDI FARMACEUTICO IDONEO DONDE LOS MICROORGANISMOS RETIENEN SU VIABILIDAD. TAMBIEN SE DESCRIBE EL EMPLEO DEL PREPARADO EN LA PROFILAXIS CONTRA Y/O EL TRATAMIENTO DE LA TONSILITIS (BETA)-ESTREPTOCOCICA.
ES90903444T 1989-02-15 1990-02-12 Preparado farmaceutico util en el tratamiento de la amigdalitis. Expired - Lifetime ES2091818T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900510A SE463349B (sv) 1989-02-15 1989-02-15 Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit

Publications (1)

Publication Number Publication Date
ES2091818T3 true ES2091818T3 (es) 1996-11-16

Family

ID=20375049

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90903444T Expired - Lifetime ES2091818T3 (es) 1989-02-15 1990-02-12 Preparado farmaceutico util en el tratamiento de la amigdalitis.

Country Status (28)

Country Link
US (1) US5378459A (es)
EP (1) EP0458855B1 (es)
CN (1) CN1046099A (es)
AR (1) AR247099A1 (es)
AT (1) ATE142503T1 (es)
AU (1) AU628493B2 (es)
CA (1) CA2047189A1 (es)
CS (1) CS74890A2 (es)
DD (1) DD291926A5 (es)
DE (1) DE69028520T2 (es)
DK (1) DK0458855T3 (es)
EG (1) EG19075A (es)
ES (1) ES2091818T3 (es)
FI (1) FI101452B1 (es)
GR (1) GR1000639B (es)
HU (1) HU209915B (es)
IE (1) IE900459L (es)
IL (1) IL93242A (es)
IS (1) IS1678B (es)
MY (1) MY106487A (es)
NO (1) NO178883C (es)
NZ (1) NZ232381A (es)
PH (1) PH27203A (es)
PT (1) PT93141A (es)
SE (1) SE463349B (es)
WO (1) WO1990009186A1 (es)
YU (1) YU23490A (es)
ZA (1) ZA90692B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705152A (en) * 1990-10-26 1998-01-06 Interprise Limited Antimicrobial composition
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
SE511648C2 (sv) * 1998-04-17 1999-11-01 Bacterum Ab Streptokockpreparat för behandling av öroninflammation
RU2279481C2 (ru) 1999-10-12 2006-07-10 Блис Текнолоджис Лимитед Лантибиотик
DE10139039A1 (de) * 2001-08-08 2003-05-08 Zinon Douvlis Medikamentöse Suppression maligner Proliferationsprozesse durch Aminosäuren und Aminosäurenbindungen orientierte Reaktionen
US20110256179A1 (en) 2008-11-17 2011-10-20 Essum Ab Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
CN108135200B (zh) 2015-10-01 2022-06-28 多伦多大学管理委员会 铁强化茶制品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1195613A (en) * 1981-02-17 1985-10-22 Forsyth Dental Infirmary For Children Method of treating periodontosis
US4454109A (en) * 1981-02-17 1984-06-12 Forsyth Dental Infirmary For Children Method of treating periodontosis
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤

Also Published As

Publication number Publication date
IS3547A7 (is) 1990-08-16
DD291926A5 (de) 1991-07-18
GR900100092A (en) 1991-06-28
DE69028520T2 (de) 1997-04-03
NO913162L (no) 1991-10-07
CN1046099A (zh) 1990-10-17
GR1000639B (el) 1992-09-11
NZ232381A (en) 1992-10-28
AU5157790A (en) 1990-09-05
NO178883B (no) 1996-03-18
US5378459A (en) 1995-01-03
SE8900510D0 (sv) 1989-02-15
FI101452B (fi) 1998-06-30
EG19075A (en) 1994-06-30
NO913162D0 (no) 1991-08-13
SE463349B (sv) 1990-11-12
DK0458855T3 (da) 1996-09-30
ZA90692B (en) 1990-10-31
IE900459L (en) 1990-08-15
HUT57051A (en) 1991-11-28
AR247099A1 (es) 1994-11-30
AU628493B2 (en) 1992-09-17
EP0458855B1 (en) 1996-09-11
ATE142503T1 (de) 1996-09-15
IL93242A (en) 1994-11-28
CS74890A2 (en) 1991-09-15
NO178883C (no) 1996-06-26
HU209915B (en) 1994-11-28
CA2047189A1 (en) 1990-08-16
IS1678B (is) 1997-12-31
PH27203A (en) 1993-05-04
PT93141A (pt) 1990-08-31
EP0458855A1 (en) 1991-12-04
IL93242A0 (en) 1990-11-29
SE8900510L (sv) 1990-08-16
FI101452B1 (fi) 1998-06-30
FI913845A0 (fi) 1991-08-14
YU23490A (sh) 1993-05-28
DE69028520D1 (de) 1996-10-17
MY106487A (en) 1995-06-30
WO1990009186A1 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
Richet et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients
Bassett et al. Wound infection with Pseudomonas multivorans: a water-borne contaminant of disinfectant solutions
Gold-Deutch et al. How does infected bile affect the postoperative course of patients undergoing laparoscopic cholecystectomy?
Paine Jr et al. Bacteriologic studies on aureomycin
ATE400281T1 (de) Vaginales lactobacillus-medikament
ATE135228T1 (de) Pharmazeutische zubereitung zur kontrolle pathogener intestinaler bakterien
Møller et al. Changing patterns of plasmid-mediated drug resistance during tetracycline therapy
Sutter et al. Sources of Pseudomonas aeruginosa infection in burns: study of wound and rectal cultures with phage typing.
ES2091818T3 (es) Preparado farmaceutico util en el tratamiento de la amigdalitis.
Ramakrishnan A leaf spot disease of zingiber officinale caused by Phyllosticta zingiberi n. sp.
Hsu et al. Antibacterial substances from staphylococci
Van den Broek et al. The pathogenesis of ecthyma gangrenosum
Williams et al. Routine daily surveillance cultures in the management of CAPD patients
Krajden et al. Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain.
Schraibman The bacteriology of leg ulcers
CHAMBERS et al. A fungistatic strain of Bacillus subtilis isolated from normal toes
Oldfield III et al. Empirical Treatment of Shigella Dysentery with Trimethoprim: Five-Day Course Versus Single Dose
Beaman et al. The timing of exposure of mononuclear phagocytes to recombinant interferon γ and recombinant tumor necrosis factor α alters interactions with Nocardia asteroides
SUBBA et al. Original observations of Filippo Pacini on Vibrio cholera
DONALDSON et al. Use of glucuronolactone with streptomycin for reducing bacterial flora of the colon
Wesselhoeft Factors influencing the incidence and course of otitis media in scarlet fever
JO1737B1 (en) Pharmaceutical preparations used to treat tonsillitis
Lundberg et al. Adherence in the colonization of Streptococcus pneumoniae in the nasopharynx in children
Dy et al. β glucuronidase in macrophages of skinallografted mice—II: Demonstration of a lymphokine decreasing macrophage β glucuronidase in allograft immunity
Kumala et al. The Antibacterial Effectivity of Ethanol Extract of Red Grape (Vitis vinifera Variant Red globe) as a Root Canal Irrigation Material Against the Growth of Actinomyces spp. Bacteria in Vitro

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 458855

Country of ref document: ES